日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial

在接受 BNT162b2 COVID-19 疫苗初次接种后，接受积极治疗的实体瘤患者体内针对 SARS-CoV-2 的特异性体液和细胞免疫反应模式：来自 IV 期 CoVigi 试验的结果

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251316224
Obermannova, Radka Lordick; Selingerova, Iveta; Demlova, Regina; Okruhlicova, Dominika; Nevrlka, Jiri; Cerna-Pilatova, Katerina; Greplova, Kristina; Cermakova, Zdenka; Valik, Dalibor; Kiss, Igor; Palacova, Marketa; Poprach, Alexandr; Lejdarova, Hana; Selvekerova, Sarka; Vaneckova, Martina; Zdrazilova-Dubska, Lenka
SARS-CoV-2
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors

Tazemetostat 在儿童 INI1 阴性恶性横纹肌样瘤治疗中的应用

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-48774-2
Vejmelkova, Klara; Pokorna, Petra; Noskova, Kristyna; Faustmannova, Anna; Drabova, Klara; Pavelka, Zdenek; Bajciova, Viera; Broz, Martin; Tinka, Pavel; Jezova, Marta; Palova, Hana; Kren, Leos; Valik, Dalibor; Slaby, Ondrej; Sterba, Jaroslav
发表日期：2023
文献求助 收藏

Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practice

急诊药物治疗会影响酶法测定血浆肌酐的准确性：真实世界临床证据及其对临床实践的影响

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2023.1236948
Demlova, Regina; Kozakova, Sarka; Rihacek, Michal; Buckova, Dana; Horska, Katerina; Wiewiorka, Ondrej; Boucek, Lubos; Selingerova, Iveta; Podborska, Martina; Korberova, Alena; Mikuskova, Alena; Starha, Jiri; Benovska, Miroslava; Radina, Martin; Richter, Michal; Zdrazilova Dubska, Lenka; Valik, Dalibor
发表日期：2023
文献求助 收藏

Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the future

重新审视恶性淋巴瘤患者治疗相关心脏毒性——回顾与展望

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2023.1243531
Rihackova, Eva; Rihacek, Michal; Vyskocilova, Maria; Valik, Dalibor; Elbl, Lubomir
毒理研究
淋巴瘤
发表日期：2023
文献求助 收藏

Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing

癌症患者微小残留病灶指导的间歇给药：采用间歇性劳拉替尼治疗化疗耐药性间变性大细胞淋巴瘤的成功案例

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO.21.00525
Pokorna, Petra; Lakka Klement, Giannoula; Vasikova, Alzbeta; Kanderova, Veronika; Jezova, Marta; Noskova, Kristyna; Mudry, Peter; Kyr, Michal; Merta, Tomas; Bajciova, Viera; Krenova, Zdenka; Palova, Hana; Valik, Dalibor; Zdrazilova Dubska, Lenka; Slaby, Ondrej; Sterba, Jaroslav
细胞生物学
肿瘤
淋巴瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)-Exploring Its Possible Clinical Relevance in Cancer Patients

舒尼替尼诱导的平均红细胞体积（MCV）升高——探讨其在癌症患者中的潜在临床意义

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol29060330
Rihacek, Michal; Selingerova, Iveta; Kocak, Ivo; Kocakova, Ilona; Rihackova, Eva; Valik, Dalibor; Sterba, Jaroslav
细胞生物学
肿瘤
肿瘤免疫
红细胞
发表日期：2022
文献求助 收藏

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside

复发/难治性儿童伯基特淋巴瘤的全面分子谱分析——三个真实临床病例的回顾性分析——探讨床旁随机化和个体化治疗方案的问题

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2019.01531
Polaskova, Kristyna; Merta, Tomas; Martincekova, Alexandra; Zapletalova, Danica; Kyr, Michal; Mazanek, Pavel; Krenova, Zdenka; Mudry, Peter; Jezova, Marta; Tuma, Jiri; Skotakova, Jarmila; Cervinkova, Ivana; Valik, Dalibor; Zdrazilova-Dubska, Lenka; Noskova, Hana; Pal, Karol; Slaby, Ondrej; Fabian, Pavel; Kozakova, Sarka; Neradil, Jakub; Veselska, Renata; Kanderova, Veronika; Hrusak, Ondrej; Freiberger, Tomas; Klement, Giannoula Lakka; Sterba, Jaroslav
淋巴瘤
发表日期：2019
文献求助 收藏

Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome

树突状细胞免疫疗法在晚期肉瘤和神经母细胞瘤儿童患者中的应用：单核细胞采集前的抗癌治疗会损害树突状细胞的免疫刺激和抗原呈递行为以及生产工艺结果

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2019.01034
Hlavackova, Eva; Pilatova, Katerina; Cerna, Dasa; Selingerova, Iveta; Mudry, Peter; Mazanek, Pavel; Fedorova, Lenka; Merhautova, Jana; Jureckova, Lucie; Semerad, Lukas; Pacasova, Rita; Flajsarova, Lucie; Souckova, Lenka; Demlova, Regina; Sterba, Jaroslav; Valik, Dalibor; Zdrazilova-Dubska, Lenka
肿瘤
肿瘤免疫
树突状细胞
单核细胞
细胞生物学
树突状细胞
免疫/内分泌
发表日期：2019
文献求助 收藏

Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities

针对H3K27M突变型儿童弥漫性胶质瘤的个性化治疗提供了更好的治疗机会

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2019.01436
Gojo, Johannes; Pavelka, Zdenek; Zapletalova, Danica; Schmook, Maria T; Mayr, Lisa; Madlener, Sibylle; Kyr, Michal; Vejmelkova, Klara; Smrcka, Martin; Czech, Thomas; Dorfer, Christian; Skotakova, Jarmila; Azizi, Amedeo A; Chocholous, Monika; Reisinger, Dominik; Lastovicka, David; Valik, Dalibor; Haberler, Christine; Peyrl, Andreas; Noskova, Hana; Pál, Karol; Jezova, Marta; Veselska, Renata; Kozakova, Sarka; Slaby, Ondrej; Slavc, Irene; Sterba, Jaroslav
胶质瘤
发表日期：2019
文献求助 收藏

Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment

实体瘤患者髓系来源抑制细胞（MDSC）：粒细胞集落刺激因子治疗的考量

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-018-2166-4
Pilatova, Katerina; Bencsikova, Beatrix; Demlova, Regina; Valik, Dalibor; Zdrazilova-Dubska, Lenka
MDSC
细胞生物学
粒细胞
发表日期：2018
文献求助 收藏